Jamie Christensen - 24 May 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP & Chief Scientific Officer
Signature
/s/ Laurie Stelzer, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2023
Net transactions value
-$28,035
Form type
4
Filing time
24 May 2023, 19:38:25 UTC
Previous filing
24 Jan 2023
Next filing
10 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $28,035 -619 -0.5% $45.29 124,123 24 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on May 21, 2020.